A Look at Collegium Pharmaceutical's (COLL) Valuation After Upbeat Q3 Results and Raised Guidance [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Revenue and earnings both saw strong year-over-year gains, and management raised their outlook for the full year. See our latest analysis for Collegium Pharmaceutical. Collegium Pharmaceutical's share price has rallied sharply on the back of its upbeat quarterly results and improved full-year outlook, jumping more than 27% over the last month and delivering a standout 48% year-to-date share price return. That recent momentum builds on a multi-year stretch of strong performance, with total shareholder returns topping 31% over the past year and more than doubling over the last three years. These results are clear signals that investors are increasingly optimistic about the company's growth potential following strategic moves such as the Jornay PM acquisition. If you're interested in discovering other compelling companies in healthcare and biotech, check out See the full list for free. With shares soaring and guidance now higher, the key question is whether Collegium Pharmaceutic
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 11/6/25 - Beat
COLL
Sec Filings
- 11/14/25 - Form 4
- 11/14/25 - Form 4
- 11/13/25 - Form SCHEDULE
- COLL's page on the SEC website